The Charlotte Lozier Institute (CLI), which equips pro-lifers with the education and research they need to advocate for the cause, has released a report about how online abortion drug sellers are breaking state laws and federal regulations.
And they’re putting women at risk.
The Supreme Court’s decision in Dobbs v. Jackson Women’s Health Organization in 2022 sent the issue of abortion back to the states.
For example, the legislature in Louisiana, a state that sued the FDA for expanding mifepristone access without safety checks, barred abortion with limited exceptions. Louisiana requires in-person doctor visits and abortion pills to be dispensed in person, but the FDA’s policy allows women to obtain prescriptions for these drugs via telemedicine and order through the mail.
CLI also found that online abortion drug sellers sold unapproved and misbranded drugs. In the report, CLI analyzed Plan C, a directory for abortion drug sellers.
And that’s not all.
“None of the five community networks (community-based groups who give U.S. women free abortion drugs) have a gestational limit at which they will stop sending abortion drugs to U.S. women,” according to CLI’s press release.
Abortion advocates call this health care? Snuffing out life in the womb is not “health care” for the woman and definitely not for the baby.
“The egregious findings of this paper should serve as a wake-up call to policymakers that a wild west of online abortion drug access only serves to end unborn life at all costs, even at the expense of women’s safety,” said Mia Steupert, CLI research associate and the report’s author.
Photo credit: American Life League (Creative Commons) – Some Rights Reserved
